Stay informed about ResearchSat publications, platform updates, and mission evidence
A chronological view of our journey from 2022 to present
Building on their initial MoU, ResearchSat and TRADE WIND BIOTECH (TWBIO) expanded their collaboration to combine ResearchSat's space engineering and ISS access with TWBIO's novel enzyme scaffold technology for future space habitats. The partnership includes joint grant applications, co-development of space habitat technologies, and TWBIO's utilization of ResearchSat's ISS experiment services.
ResearchSat partnered with HelioX Cosmos Taiwan, a space consulting firm specializing in protein crystallization and cislunar missions, to navigate the Asian market and develop joint activities including potential cislunar missions. The partnership aims to establish ResearchSat's local presence in Taiwan and demonstrate long-term commitment to the Asia-Pacific space ecosystem.
ResearchSat established a strategic partnership with Anntong Company for collaborative development of aerospace payloads, where ResearchSat will handle payload design and Anntong will manufacture specialized microfluidic chips. The collaboration focuses on ResearchSat's modular cassettes, microfluidic chip integration, and fluid manipulation capabilities for space applications.
ResearchSat was recognized among the top applicants for Taiwan's prestigious TACC+ (Taiwan Accelerator Plus) International SpaceTech Startup Supporting Program, powered by ITRI (Industrial Technology Research Institute). While placed on the waiting list, this recognition highlights ResearchSat's global competitiveness among international space technology startups and showcases the company's cutting-edge satellite technology capabilities.
Adelaide's Lot Fourteen innovation precinct profiled ResearchSat's expansion in South Australia, emphasising plans to scale bacteria‑based experiments and orbital manufacturing after earlier sub‑orbital successes.
SpaceConnect Online listed ResearchSat among Australia's five most innovative space ventures, citing AI‑driven feedback loops and scalable bioreactor design.
ResearchSat announced a strategic partnership with Dutch‑Australian cryogenic pioneer Onnes Cryogenics to integrate advanced zero‑boil‑off cooling into forthcoming bioreactor satellites, enabling temperature‑sensitive pharma workflows in orbit. The accord was celebrated during a South‑Australian trade mission to Hyderabad.
A widely‑shared LinkedIn post explored how microgravity modulates stem‑cell pathways, positioning space bioprocessing as a cornerstone for next‑gen therapies.
In a long‑form article, ResearchSat detailed its roadmap for in‑space tissue engineering, drug discovery, and food‑tech applications of its proprietary ADI‑Lab platform.
Explore ResearchSat publications and evidence-led updates
Groundbreaking research on microgravity-induced changes in gene expression and cellular morphology published in prestigious Nature journal...
Our comprehensive review of space-based biological research platforms published in Frontiers journal...